Investor Relations

Marrone Bio Innovations Inc. (MBI) (NASDAQ: MBII) provides biological based solutions for agricultural crops, turf protection, seed treatment, plant health and waterway systems. As a leader in alternatives to conventional pesticides, MBII has a proven go-to-market strategy and remains on the cutting edge of developing the types of biological products in which today’s farmers are increasingly interested.

Canaccord Genuity AgriFood Tech Innovation Virtual Forum

December 3, 2020

Marrone Bio Innovations will present at the Canaccord Genuity AgriFood Tech Innovation Virtual Forum at 1:30 p.m. Eastern Time

Latest Video Update

August 2020

Newly appointed CEO, Kevin Helash, shares his background, what brought him to Marrone Bio Innovations and insights on the company's Q2 earnings results.

MBII Stock

Press Releases

Global Adoption of Biologicals Accelerates as Marrone Bio’s Grandevo® WDG Bioinsecticide is Approved for Use in New Zealand, Chile and on Hemp in the U.S.

January 14, 2021Press Releases

Marrone Bio Innovations Announces Effectiveness of Form S-3 Resale Registration Statement

January 5, 2021Press Releases

Marrone Bio Provides Update on Warrant Transactions; No New Securities Offered

January 5, 2021Press Releases

PGG Wrightson Seeds to Distribute Marrone Bio Innovations’ Pro Farm UBP Seed Treatment in Uruguay

December 21, 2020Press Releases

Marrone Bio Innovations, Inc. Reports Third-Quarter 2020 Financial Results

November 9, 2020Press Releases

Marrone Bio Innovations Appoints Lara L. Lee to Board of Directors

November 2, 2020Press Releases

Presentations & Interviews

See Presentations Library for more.

Settlement of Shareholder Derivative Lawsuits

Notice of Pendency of Proposed Settlement of Stockholder Derivative Action

Stipulation of Settlement